AbCellera director reports 50,000-share charitable gift

Q: What insider transaction did AbCellera Biologics Inc. (ABCL) report on August 11, 2026?

AbCellera Biologics Inc. reported that director Michael R. Hayden made a bona fide charitable gift of 50,000 Common Shares on August 11, 2026 through Genworks 2 Consulting, Inc., an entity associated with his spouse.

Q: How many AbCellera (ABCL) shares were donated in Michael R. Hayden’s Form 4 filing?

The Form 4 shows a charitable donation of 50,000 Common Shares of AbCellera Biologics Inc., made by Genworks 2 Consulting, Inc. on August 11, 2026, and reported as a bona fide gift transaction.

Q: Who holds voting and investment power over the donated AbCellera (ABCL) shares?

The filing states that the reporting person’s spouse has sole voting and investment power over the shares held by Genworks 2 Consulting, Inc. Michael R. Hayden disclaims beneficial ownership except for any indirect pecuniary interest.

Q: Was the AbCellera (ABCL) gift transaction executed under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as relying on such a plan. There is no footnote stating that the 50,000-share charitable gift was executed pursuant to a Rule 10b5-1 trading arrangement.

AbCellera Biologics Inc. director Michael R. Hayden reported a bona fide charitable gift of 50,000 Common Shares on August 11, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

AbCellera Biologics Inc. director Michael R. Hayden reported a bona fide charitable gift of 50,000 Common Shares on August 11, 2026. The donation was made by Genworks 2 Consulting, Inc., which now holds 1,273,397 Common Shares. These shares are held with sole voting and investment power by the reporting person’s spouse, and the reporting person disclaims beneficial ownership except for any indirect pecuniary interest. A separate indirect holding of 118,245 Common Shares is reported as held by the spouse.

Insider Trade Summary

50,000 shares gifted

Gift 2 txns

Insider Hayden Michael R

Role Director

Type	Security	Shares	Price	Value
Gift	Common Shares ^{F1, F2}	50,000	$0.00	$0.00
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 1,273,397 shares (Indirect, See footnote); Common Shares — 118,245 shares (Indirect, By spouse)

Footnotes (2)

F1. This transaction represents a charitable donation of 50,000 common shares made by Genworks 2 Consulting, Inc. on August 11, 2026.
F2. These shares are held by Genworks 2 Consulting, Inc. The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2 Consulting, Inc. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Key Figures

Charitable gift: 50,000 Common Shares Gift price per share: $0.0000 Genworks 2 holdings: 1,273,397 Common Shares +1 more

4 metrics

Charitable gift 50,000 Common Shares Bona fide gift on August 11, 2026 by Genworks 2 Consulting, Inc.

Gift price per share $0.0000 Reported transaction price per share for the 50,000-share gift

Genworks 2 holdings 1,273,397 Common Shares Indirect holdings following the charitable gift transaction

Spouse indirect holdings 118,245 Common Shares Separate indirect position reported as held by spouse

Key Terms

bona fide gift, indirect pecuniary interest, sole voting and investment power

3 terms

bona fide gift financial

"The transaction code description states it is a bona fide gift."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

indirect pecuniary interest financial

"The reporting person disclaims beneficial ownership except for any indirect pecuniary interest."

sole voting and investment power financial

"The reporting person’s spouse has sole voting and investment power over the shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AbCellera Biologics Inc. (ABCL) report on August 11, 2026?

AbCellera Biologics Inc. reported that director Michael R. Hayden made a bona fide charitable gift of 50,000 Common Shares on August 11, 2026 through Genworks 2 Consulting, Inc., an entity associated with his spouse.

How many AbCellera (ABCL) shares were donated in Michael R. Hayden’s Form 4 filing?

The Form 4 shows a charitable donation of 50,000 Common Shares of AbCellera Biologics Inc., made by Genworks 2 Consulting, Inc. on August 11, 2026, and reported as a bona fide gift transaction.

Who holds voting and investment power over the donated AbCellera (ABCL) shares?

The filing states that the reporting person’s spouse has sole voting and investment power over the shares held by Genworks 2 Consulting, Inc. Michael R. Hayden disclaims beneficial ownership except for any indirect pecuniary interest.

What are Michael R. Hayden’s indirect holdings in AbCellera (ABCL) after the reported gift?

After the transaction, Genworks 2 Consulting, Inc. is reported holding 1,273,397 Common Shares indirectly, and a separate indirect position of 118,245 Common Shares is reported as held by the spouse, both attributed as indirect ownership.

Was the AbCellera (ABCL) gift transaction executed under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as relying on such a plan. There is no footnote stating that the 50,000-share charitable gift was executed pursuant to a Rule 10b5-1 trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/13/2026 - 03:01 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayden Michael R

(Last)

(First)

(Middle)

C/O ABCELLERA BIOLOGICS INC

150 W 4TH AVENUE

(Street)

VANCOUVER

(City)

(State)

(Zip)

BRITISH COLUMBIA, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
AbCellera Biologics Inc. [ ABCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	08/11/2026		G	V	50,000	D	$0⁽¹⁾	1,273,397	I⁽²⁾	See footnote
Common Shares								118,245	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction represents a charitable donation of 50,000 common shares made by Genworks 2 Consulting, Inc. on August 11, 2026.

2. These shares are held by Genworks 2 Consulting, Inc. The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2 Consulting, Inc. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Remarks:

	Tryn Stimart, attorney-in-fact	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR